1 2 3 4 5 6 7 8

7. Bibliographie

1. Agrawal NK, Goyal R, Rastogi A, Naik D, Singh SK : Thyroid hormone resistance. Postgrad Med J 84:473–477, 2008 C4
2. Arita K, Kurisu K, Tominaga A, Sugiyama K, Ikawa F, Yoshioka H, et al. : Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg 95:897–901, 2001 C4
3. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL : Acute management of pituitary apoplexy—surgery or conservative management ? Clin Endocrinol (Oxf) 61:747–752, 2004 C4
4. Bahuleyan B, Raghuram L, Rajshekhar V, Chacko AG : To assess the ability of MRI to predict consistency of pituitary macroadenomas. Br J Neurosurg 20:324–326, 2006 B2
5. Bessac L, Bachelot I, Vasdev A, Martinie M, Bonnier L, Chabre O, et al. : [Catheterization of the inferior petrosal sinus. Its role in the diagnosis of Cushing’s syndrome. Experience with 23 explorations]. Ann Endocrinol (Paris) 53:16–27, 1992 C4
6. Biller BMK, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, et al. : Treatment of adrenocorticotropin-dependent Cushing’s syndrome : a consensus statement. J Clin Endocrinol Metab 93:2454–2462, 2008 A1
7. Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, et al. : Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol 150:763–771, 2004 B2
8. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD : Thyrotropin-secreting pituitary tumors : diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476–486, 1999 C4
9. Brue T, Delemer B : Diagnosis and management of hyperprolactinemia : expert consensus - French Society of Endocrinology. Ann Endocrinol (Paris) 68:58–64, 2007 A1
10. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ : Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E5, 2010 C4
11. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, et al. : Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265–273, 2006 A1
12. Castinetti F, Morange I, Dufour H, Jaquet P, Conte-Devolx B, Girard N, et al. : Desmopressin test during petrosal sinus sampling : a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome. Eur J Endocrinol 157:271–277, 2007 C2
13. Castinetti F, Nagai M, Dufour H, Kuhn J-M, Morange I, Jaquet P, et al. : Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease. Eur J Endocrinol 156:91–98, 2007 C2
14. Chanson P, Bertherat J, Beckers A, Bihan H, Brue T, Caron P, et al. : French consensus on the management of acromegaly. Ann Endocrinol (Paris) 70:92–106, 2009 A1
15. Chen Y, Li ZF, Zhang FX, Li JX, Cai L, Zhuge QC, et al. : Gamma knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas : a systematic review and meta-analysis. Eur J Endocrinol 169:487–495, 2013 B2
16. Chinezu L, Vasiljevic A, Jouanneau E, François P, Borda A, Trouillas J, et al. : Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies. Hum Pathol 45:71–77, 2014 B2
17. Colao A, Di Sarno A, Guerra E, Pivonello R, Cappabianca P, Caranci F, et al. : Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. Clin Endocrinol (Oxf) 67:426–433, 2007 B2
18. Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S : Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 15:905–915, 2008 C4
19. Colao A, Filippella M, Di Somma C, Manzi S, Rota F, Pivonello R, et al. : Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas. Endocrine 20:279–283, 2003 C4
20. Cottier JP, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, et al. : Cavernous sinus invasion by pituitary adenoma : MR imaging. Radiology 215:463–469, 2000 B2
21. Cushing H : The pituitary and ist disorders. Classics of Medecine., Birmingham, 1979 C4
22. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, et al. : Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 77:1352–1355, 1993 C4
23. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, et al. : Recognition of gonadotroph adenomas in women. N Engl J Med 324:589–594, 1991C4
24. DeLellis R, Lloyd R, Heitz P, Eng C : Tumours of endocrine organs, in World Health Organization classification of tumors, IARC. Lyon A1
25. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J : Sex-related difference in the growth of prolactinomas : a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102–2107, 1997 B2
26. Dudziak K, Honegger J, Bornemann A, Horger M, Müssig K : Pituitary carcinoma with malignant growth from first presentation and fulminant clinical course—case report and review of the literature. J Clin Endocrinol Metab 96:2665–2669, 2011 C4
27. Ebner FH, Kuerschner V, Dietz K, Bueltmann E, Naegele T, Honegger J : Reduced intercarotid artery distance in acromegaly : pathophysiologic considerations and implications for transsphenoidal surgery. Surg Neurol 72:456–460 ; discussion 460, 2009 C4
28. Estrada J, Boronat M, Mielgo M, Magallón R, Millan I, Díez S, et al. : The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177, 1997 C4
29. Galen : Galen on the usefulness of the parts of the body (Peri Chreias Moion), in Cornell Universiy Press. Ithaca, NY, 1968 C4
30. Garcia T, Sanchez S, Litré CF, Radoi C, Delemer B, Rousseaux P, et al. : Prognostic value of retinal nerve fiber layer thickness for postoperative peripheral visual field recovery in optic chiasm compression. J Neurosurg 121:165–169, 2014 C4
31. Iwata H, Sato K, Tatewaki K, Yokota N, Inoue M, Baba Y, et al. : Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma : high local control with low toxicity. Neuro-oncology 13:916–922, 2011B2
32. Jacob M, Raverot G, Jouanneau E, Borson-Chazot F, Perrin G, Rabilloud M, et al. : Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography. Am J Ophthalmol 147:64–70.e2, 2009 C4
33. Jia W, Sanders AJ, Jia G, Liu X, Lu R, Jiang WG : Expression of the mTOR Pathway Regulators in Human Pituitary Adenomas Indicates the Clinical Course. Anticancer Res 33:3123–3131, 2013 C4
34. Jouanneau E, Perrin G, Trouillas J : [Corticotroph microadenomas of the pituitary stalk. Diagnostic and therapeutic difficulties]. Neurochirurgie 48:215–222, 2002 C4
35. Jouanneau E : Les adénomes hypophysaires non fonctionnels : résultats tumoraux, endocriniens et ophtalmologiques à long terme. Thèse de Médecine, Université Lyon I, Lyon1999 C4
36. Jouanneau E, Wierinckx A, Ducray F, Favrel V, Borson-Chazot F, Honnorat J, et al. : New targeted therapies in pituitary carcinoma resistant to temozolomide. Pituitary 15:37–43, 2012 C4
37. Karavitaki N : Prevalence and incidence of pituitary adenomas. Ann Endocrinol (Paris) 73:79–80, 2012 C4
38. Knosp E, Steiner E, Kitz K, Matula C : Pituitary adenomas with invasion of the cavernous sinus space : a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617 ; discussion 617–618, 1993 C4
39. Lafferty AR, Chrousos GP : Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 84:4317–4323, 1999 C4
40. Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JA, Oskouian R : Stereotactic radiosurgery for pituitary adenomas : a review of the literature. J Neurooncol 69:257–272, 2004 C4
41. Lebbe M, Hubinont C, Bernard P, Maiter D : Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol (Oxf) 73:236–242, 2010 C4
42. Liu JK, Couldwell WT : Pituitary apoplexy in the magnetic resonance imaging era : clinical significance of sphenoid sinus mucosal thickening. J Neurosurg 104:892–898, 2006 C4
43. Maartens NF : The history of the treatment of pituitary adenomas. Endocrine 28:9–26, 2005 C4
44. Maiza JC, Vezzosi D, Matta M, Donadille F, Loubes-Lacroix F, Cournot M, et al. : Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa. Clin Endocrinol (Oxf) 67:282–289, 2007 B2
45. Mancini T, Casanueva FF, Giustina A : Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 37:67–99, viii, 2008 C4
46. Marie P : Sur deux cas d’acromégalie : hypertrophie singulière, non congénitale, des extrémités supérieures, inférieures et céphalique. 6:297–333, 1886 C4
47. Mason RB, Nieman LK, Doppman JL, Oldfield EH : Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function. J Neurosurg 87:343–351, 1997 C4
48. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, et al. : Guidelines for acromegaly management : an update. J Clin Endocrinol Metab 94:1509–1517, 2009 A1
49. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. : Diagnosis and treatment of hyperprolactinemia : an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273–288, 2011 A1
50. Messerer M, De Battista JC, Raverot G, Kassis S, Dubourg J, Lapras V, et al. : Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30:E11, 2011 C4
51. Messerer M, Dubourg J, Raverot G, Bervini D, Berhouma M, George I, et al. : Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic. Clin Neurol Neurosurg 115:2514–2520, 2013 C4
52. Minniti G, Scaringi C, Enrici RM : Radiation techniques for acromegaly. Radiat Oncol 6:167, 2011 C4
53. Ónnestam L, Berinder K, Burman P, Dahlqvist P, Engström BE, Wahlberg J, et al. : National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 98:626–635, 2013 C4
54. Ortiz LD, Syro LV, Scheithauer BW, Ersen A, Uribe H, Fadul CE, et al. : Anti-VEGF therapy in pituitary carcinoma. Pituitary 15:445–449, 2012 C4
55. Perrin G, Stevenaert A, Jouanneau E : [Technical aspects and surgical strategy for removal of corticotroph pituitary adenoma]. Neurochirurgie 48:186–214, 2002 C4
56. Petersenn S, Farrall AJ, Block C, Melmed S, Schopohl J, Caron P, et al. : Long-term efficacy and safety of subcutaneous pasireotide in acromegaly : results from an open-ended, multicenter, Phase II extension study. Pituitary:2013 B2
57. Pita-Gutierrez F, Pertega-Diaz S, Pita-Fernandez S, Pena L, Lugo G, Sangiao-Alvarellos S, et al. : Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome : a systematic review and meta-analysis. PLoS ONE 8:e61523, 2013 C4
58. Potorac I, Petrossians P, Daly AF, Schillo F, Ben Slama C, Nagi S, et al. : Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer:2015 B2
59. Primeau V, Raftopoulos C, Maiter D : Outcomes of transsphenoidal surgery in prolactinomas : improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 166:779–786, 2012 C4
60. Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. : UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 74:9–20, 2011 A1
61. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA : Classical pituitary apoplexy : clinical features, management and outcome. Clin Endocrinol (Oxf) 51:181–188, 1999 C4
62. Raverot G, Vasiljevic A, Raverot V, Lapras V, Favrel V, Trouillas J, et al. : Les adénomes hypophysaires gonadotropes, in EMC. 2014 C4
63. Raverot G, Wierinckx A, Jouanneau E, Auger C, Borson-Chazot F, Lachuer J, et al. : Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing’s disease. 35–43, 2010 C4
64. Regis J, Castinetti F : Radiosurgery : a useful first-line treatment of prolactinomas ? World Neurosurg 74:103–104, 2010 C4
65. Sasaki R, Murakami M, Okamoto Y, Kono K, Yoden E, Nakajima T, et al. : The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys 47:1337–1345, 2000 C4
66. Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL, et al. : Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas : a multicenter study. J Neurosurg 119:446–456, 2013 B2
67. Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, et al. : Pituitary apoplexy : a review of clinical presentation, management and outcome in 45 cases. Pituitary 7:157–163, 2004 C4
68. Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas GA, Monson JP, et al. : Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing’s disease. Eur J Endocrinol 164:667–674, 2011 C4
69. Sun DQ, Cheng JJ, Frazier JL, Batra S, Wand G, Kleinberg LR, et al. : Treatment of pituitary adenomas using radiosurgery and radiotherapy : a single center experience and review of literature. Neurosurg Rev 34:181–189, 2010 C4
70. Suzuki C, Maeda M, Hori K, Kozuka Y, Sakuma H, Taki W, et al. : Apparent diffusion coefficient of pituitary macroadenoma evaluated with line-scan diffusion-weighted imaging. J Neuroradiol 34:228–235, 2007 C4
71. Tamasauskas A, Sinkunas K, Bunevicius A, Radziunas A, Skiriute D, Deltuva VP : Transsphenoidal surgery for microprolactinomas in women : results and prognosis. Acta Neurochir (Wien) 154:1889–1893, 2012 C4
72. Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF, Pollock BE : Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 74:147–152, 2010 C4
73. Toni R : Ancient views on the hypothalamic-pituitary-thyroid axis : an historical and epistemological perspective. Pituitary 3:83–95, 2000 C4
74. Trouillas J, Delgrange E, Jouanneau E, Maiter D, Guigard MP, Donckier J, et al. : [Prolactinoma in man : clinical and histological characteristics]. Ann Endocrinol (Paris) 61:253–257, 2000 C4
75. Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, et al. : A new prognostic clinicopathological classification of pituitary adenomas : a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123–135, 2013 B2
76. Van Varsseveld NC, Bisschop PH, Biermasz NR, Pereira AM, Fliers E, Drent ML : A long-term follow-up study of eighteen patients with thyrotropin-secreting pituitary adenomas. Clin Endocrinol (Oxf):2013 C4
77. Vlaeminck-Guillem V, Wémeau JL : [Thyroid hormone resistance syndromes : clinical aspects]. Rev Med Interne 20:1114–1122, 1999 C4
78. Vroonen L, Jaffrain-Rea M-L, Petrossians P, Tamagno G, Chanson P, Vilar L, et al. : Prolactinomas resistant to standard doses of cabergoline : a multicenter study of 92 patients. Eur J Endocrinol 167:651–662, 2012 C4
79. Wind JJ, Lonser RR, Nieman LK, DeVroom HL, Chang R, Oldfield EH : The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing’s disease. J Clin Endocrinol Metab 98:2285–2293, 2013 B2
80. Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr : Atypical pituitary adenomas : incidence, clinical characteristics, and implications. J Neurosurg 114:336–344, 2011 C4

1 2 3 4 5 6 7 8